Postmenopausal estrogens and risk of myocardial infarction in diabetic women

Diabetes Care
R C KaplanB M Psaty

Abstract

The effect of hormone replacement therapy on the risk of myocardial infarction in diabetic women has not been well studied. We conducted a case-control study of postmenopausal estrogen use and risk of incident myocardial infarction (MI) in pharmacologically treated diabetic women enrolled at Group Health Cooperative of Puget Sound, a large health maintenance organization in the state of Washington. Case subjects (n = 212) were all postmenopausal women with treated diabetes who sustained an incident fatal or nonfatal MI between July 1986 and December 1994. Control subjects (n = 122) were treated diabetic women drawn from a stratified random sample of postmenopausal women without prior MI. Computerized pharmacy data and medical records were used to measure use of estrogens. Cardiovascular risk factors recorded from medical records, computerized pharmacy and laboratory data, and telephone interviews were used as adjustment variables. In this study 8.5% of case and 13.9% of control subjects were current users of estrogens. The relative risk (RR) of MI for current estrogen users was 0.51 (95% CI 0.22-1.15) relative to never users, adjusted for age, study year, weight, angina, and duration of treated diabetes. Among current estrogen ...Continue Reading

Associated Clinical Trials

Citations

Oct 3, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·P J ManningS D Jones
Jun 8, 2001·Journal of Women's Health & Gender-based Medicine·W T Cefalu
Apr 28, 2004·ILAR Journal·Cristin M Bruns, Joseph W Kemnitz
Mar 16, 2005·Treatments in Endocrinology·Aun-Yeong Chong, Gregory Y H Lip
Jun 1, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Susan E BromleyRichard D T Farmer
Dec 23, 2003·Diabetes, Obesity & Metabolism·A R ScottUNKNOWN Kliofem Study Collaborative Group
Jul 17, 2003·Journal of the American Academy of Nurse Practitioners·Judith C Longworth
Sep 30, 2003·Diabetes Care·Katherine M NewtonWilliam Barlow
Sep 30, 2003·Diabetes Care·Elizabeth Barrett-Connor
Apr 6, 2005·The Journal of Nutritional Biochemistry·Kirty S SolankyAedin Cassidy
Dec 3, 1999·Stroke; a Journal of Cerebral Circulation·I C WestendorpJ C Witteman
Jun 18, 1999·The Journal of Clinical Endocrinology and Metabolism·J R KasetaJ R Sowers
Apr 19, 2002·Journal of Applied Physiology·Esther M Brooks-AsplundDan E Berkowitz
Feb 24, 2000·The Medical Clinics of North America·L H Kuller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.